Quick Answer
OptimizeRx Corp reported Shares Outstanding of 18.76 million shares for fiscal year 2025.
OptimizeRx Corp Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 18.76M | +1.7% |
| 2024 | 18.45M | +0.9% |
| 2022 | 18.29M | +2.4% |
| 2021 | 17.86M | +17.3% |
| 2020 | 15.22M | +4.2% |
| 2019 | 14.61M | +21.4% |
| 2018 | 12.04M | +23.2% |
| 2017 | 9.77M | -67.1% |
| 2016 | 29.72M | +2.4% |
| 2015 | 29.03M | +27.0% |
| 2014 | 22.87M | +54.3% |
| 2013 | 14.82M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 18.59M | — | +0.2% |
| June 30, 2025 | 18.56M | — | +0.3% |
| March 31, 2025 | 18.49M | — | +0.2% |
| December 31, 2024 | 18.45M | — | +0.4% |
| September 30, 2023 | 18.39M | +0.7% | +0.1% |
| June 30, 2023 | 18.38M | +1.1% | +0.2% |
| March 31, 2023 | 18.33M | +2.4% | +0.2% |
| December 31, 2022 | 18.29M | +2.4% | +0.1% |
- OptimizeRx Corp showed an increase of +1.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, OptimizeRx Corp’s shares outstanding has grown by 26.6% (from 14.82 million shares to 18.76 million shares).
- The most recent figure is from OptimizeRx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: